Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 476 | reported | 17 Feb 2026 | tx 5+27,415−898 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 687 | — | |
| 17 Feb 2026 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 211 | — | |
| 17 Feb 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 687 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 20,531 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 6,197 | 0.00 USD | deriv |